Premium Nahrungsergänzungsmittel | artgerecht

Acetylation Markers – Epigenetics & Significance

Acetylation markers are epigenetic indicators that show whether specific proteins or DNA-associated structures are acetylated. They play a key role in gene regulation and disease diagnostics.

Regular tips about health Regular tips about health

Things worth knowing about "Acetylation Markers"

Acetylation markers are epigenetic indicators that show whether specific proteins or DNA-associated structures are acetylated. They play a key role in gene regulation and disease diagnostics.

What Are Acetylation Markers?

Acetylation markers are biochemical indicators that reveal where an acetylation event has occurred on a protein or DNA-associated structure. During acetylation, an acetyl group (CH₃CO–) is chemically attached to a molecule – most commonly to a lysine residue on a histone protein. This process is catalysed by enzymes known as histone acetyltransferases (HATs) and can be reversed by histone deacetylases (HDACs).

Acetylation markers belong to the field of epigenetics – the study of changes in gene activity that do not involve alterations to the underlying DNA sequence. They are therefore a vital tool for understanding how genes are switched on or off without any change to the actual genetic code.

Biological Significance of Acetylation

The acetylation of histones – the proteins around which DNA is wound – profoundly influences how accessible the DNA is to transcription factors and RNA polymerases. Hyperacetylation (increased acetylation) loosens the chromatin structure and generally promotes gene expression, while hypoacetylation compacts chromatin and silences genes.

Histone H3 acetylation at lysine 9 (H3K9ac): Considered a marker of actively transcribed gene regions.
Histone H3 acetylation at lysine 27 (H3K27ac): Associated with active enhancer elements that regulate gene activity from a distance.
Histone H4 acetylation: Involved in DNA repair and chromatin organisation.

Clinical Relevance and Applications

Cancer Research and Oncology

Altered acetylation patterns are a hallmark of many cancers. Tumour cells frequently display global changes in histone acetylation that contribute to uncontrolled cell proliferation. Acetylation markers are therefore being intensively studied as potential biomarkers for cancer diagnosis and as targets for new therapies (e.g., HDAC inhibitors).

Neurodegenerative Diseases

In conditions such as Alzheimer disease and Parkinson disease, altered acetylation patterns have been observed in the brain. Acetylation markers may help identify early epigenetic changes before clinical symptoms appear.

Inflammatory and Autoimmune Disorders

The regulation of immune cells is strongly influenced by acetylation processes. Altered acetylation markers have been described in conditions such as rheumatoid arthritis and systemic lupus erythematosus.

Metabolic Syndrome and Diabetes

Epigenetic changes, including acetylation, play a role in the development of type 2 diabetes and obesity. Certain acetylation markers may indicate impaired insulin signalling or inflammatory processes.

Measurement and Diagnostics

Acetylation markers are typically detected using the following laboratory methods:

Chromatin Immunoprecipitation (ChIP): Enables genome-wide mapping of acetylation markers at specific gene loci.
ChIP Sequencing (ChIP-Seq): Combines ChIP with high-throughput sequencing for precise genome-wide analysis.
Mass Spectrometry: Used to quantitatively detect specific acetylated amino acids.
Immunohistochemistry and Western Blot: Allow detection of acetylated proteins in tissue samples and cell extracts.

Therapeutic Approaches

Understanding acetylation markers has led to the development of new drug classes. HDAC inhibitors (e.g., vorinostat, romidepsin) are already used in cancer therapy and aim to inhibit the deacetylation of histones, thereby restoring the expression of tumour suppressor genes. Further compounds that specifically modulate acetylation processes are currently under clinical investigation.

References

Kouzarides T. – Chromatin Modifications and Their Function. Cell, 128(4):693–705, 2007. DOI: 10.1016/j.cell.2007.02.005
Bhaumik SR, Smith E, Bhaumik A. – Covalent modifications of histones during development and disease pathogenesis. Nature Structural & Molecular Biology, 14(11):1008–1016, 2007.
World Health Organization (WHO) – Epigenetics and Human Health: Report of a WHO Scientific Group. Geneva, 2020.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.